McCormick V (MKC.V) [2025Q4] Earnings Preview: Downside Risk Amid Valuation Pressures

Forward-Looking Analysis

Analysts project 7.82% earnings growth for McCormick, with EPS expected to rise to $3.31 in 2026. The consensus rating of "Hold" reflects 4 buy ratings, 6 holds, and no sells, with a $76.50 price target (11.8% upside from $68.45). However, valuation metrics suggest risks: a PEG ratio of 4.02 (overvalued) and a P/B ratio of 3.45 (above 3). Short interest has surged 15.35% in the past month, with 5.71% of shares shorted, signaling bearish sentiment. Institutional ownership remains high at 79.74%, but insiders sold $9.64 million in shares over three months. Dividend sustainability is strong, with a 58.01% payout ratio next year, but the 2.85% yield faces pressure from a 66.44% current payout ratio. Analysts highlight a 7.82% earnings growth forecast but caution against overvaluation.

Historical Performance Review

In 2025Q3, McCormick reported revenue of $1.72 billion, net income of $225.50 million, and EPS of $0.84. Gross profit totaled $645.10 million, reflecting stable performance amid inflationary pressures. The results aligned with expectations, but growth momentum slowed compared to prior quarters, with no significant cost-cutting or margin expansion reported. The company maintained its dividend, underscoring its focus on shareholder returns despite modest top-line growth.

Additional News

Recent coverage highlights mixed sentiment: a 2.6/5 news sentiment score (0.65 average) and 11 articles tracked by MarketBeat this week. Search interest for MKC rose 50% in 30 days, while 10 new watchlist additions (100% increase) suggest growing retail attention. Institutional investors raised stakes in Q4, with Dorato Capital and Nisa Investment Advisors increasing holdings. CEO Brendan Foley’s 34.47% ownership reduction and major shareholder Lawrence Kurzius’s 16.85% stake cut highlight insider skepticism. The stock’s 23.68 P/E ratio remains below the market and sector averages, but the PEG ratio of 4.02 underscores valuation concerns. Analysts remain cautious, with JPMorgan lowering its price target to $82 and Sanford Bernstein maintaining an "outperform" rating at $87.

Summary & Outlook

McCormick’s financial health appears stable, with robust dividend coverage and institutional support, but valuation metrics and short interest signal risks. Earnings growth of 7.82% is positive, yet the PEG ratio of 4.02 and rising short interest (5.71% shares shorted) suggest overvaluation pressures. Institutional inflows and a 2.85% yield provide some support, but insider selling and bearish sentiment could weigh on the stock. The 2025Q4 report will test whether earnings meet $3.31 estimates, with a miss likely triggering further downside. Overall, the outlook is neutral to bearish, with valuation concerns and short-term volatility as key risks.